Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Angulo

Showing results (61-70 of 115) with videos related to

Pageof 12
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2005
Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver diseaseAyako Suzuki, Paul Angulo, James Lymp, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 9, 2005
Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot studyCynthia Levy, Denise M Harnois, Paul Angulo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 22, 2012
Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver diseaseFlavia D Mendes, Ayako Suzuki, Schuyler O Sanderson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 22, 2007
Open-label pilot study of folic acid in patients with nonalcoholic steatohepatitisPhunchai Charatcharoenwitthaya, Cynthia Levy, Paul Angulo, et al.
The American Journal of Gastroenterology|May 19, 2007
Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemiaAyako Suzuki, Paul Angulo, Jennifer St Sauver, et al.
New Solutions : a Journal of Environmental and Occupational Health Policy : NS|December 2, 2025
Uncovering the Factors Behind Rising Pneumoconiosis Rates: Central Appalachian Underground Coal Miners as a Case StudyYi-Hsuan Chen, John-Paul Angulo, Jürgen F Brune, et al.
Hepatology (Baltimore, Md.)|July 9, 2004
Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitisJayant A Talwalkar, Paul Angulo, C Daniel Johnson, et al.
The Journal of Surgical Research|January 21, 2012
PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferationRoberto Gedaly, Paul Angulo, Jonathan Hundley, et al.
The American Journal of Gastroenterology|April 2, 2004
Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitisKelly Burak, Paul Angulo, Tousif M Pasha, et al.
Digestive Diseases and Sciences|September 1, 2005
The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitisCynthia Levy, James Lymp, Paul Angulo, et al.
Pageof 12

Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2005
Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver diseaseAyako Suzuki, Paul Angulo, James Lymp, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 9, 2005
Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot studyCynthia Levy, Denise M Harnois, Paul Angulo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 22, 2012
Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver diseaseFlavia D Mendes, Ayako Suzuki, Schuyler O Sanderson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 22, 2007
Open-label pilot study of folic acid in patients with nonalcoholic steatohepatitisPhunchai Charatcharoenwitthaya, Cynthia Levy, Paul Angulo, et al.
The American Journal of Gastroenterology|May 19, 2007
Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemiaAyako Suzuki, Paul Angulo, Jennifer St Sauver, et al.
New Solutions : a Journal of Environmental and Occupational Health Policy : NS|December 2, 2025
Uncovering the Factors Behind Rising Pneumoconiosis Rates: Central Appalachian Underground Coal Miners as a Case StudyYi-Hsuan Chen, John-Paul Angulo, Jürgen F Brune, et al.
Hepatology (Baltimore, Md.)|July 9, 2004
Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitisJayant A Talwalkar, Paul Angulo, C Daniel Johnson, et al.
The Journal of Surgical Research|January 21, 2012
PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferationRoberto Gedaly, Paul Angulo, Jonathan Hundley, et al.
The American Journal of Gastroenterology|April 2, 2004
Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitisKelly Burak, Paul Angulo, Tousif M Pasha, et al.
Digestive Diseases and Sciences|September 1, 2005
The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitisCynthia Levy, James Lymp, Paul Angulo, et al.
Pageof 12